Sensor technologies

DarioHealth Expands Footprint in Musculoskeletal Sensor Technologies with the Upright GO S

NEW YORK, June 16, 2021 / PRNewswire / – DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapy (DTx) market, today announced the launch of the Upright GO S, a new wearable sensor based on the company’s pioneering biofeedback technologies to improve back health accessible to more people.

This new product from Upright, by Dario, is part of the company’s planned growth strategy to increase the number of memberships to the platform through business partnerships and consumer channels. Currently, Dario has over 185,000 members in its integrated suite of digital therapies for chronic and mental health needs.

“One of the strengths of Upright’s sensor-based solutions is the success of consumer adoption. The Upight GO S continues this legacy by providing a more affordable option to make digital health solutions accessible to more people in support of our mission and membership growth strategy, ”said Erez Raphael, CEO of DarioHealth.

New research published in the journal Demography documents the growing prevalence of chronic back and neck pain in American adults, with the greatest increase in pain affecting people in lower socioeconomic classes.1 Employers are also paying attention, as back pain is becoming a significant problem for their populations, especially for employees who spend a lot of time sitting. In addition, a recent survey of users of Upight by Dario found that 78% of them agree that increasing sedentary activities during the day has a negative impact on their health, further illustrating the need for preventive approaches. .

The Upright GO S represents a breakthrough in our sensor technology and responds to the demand for more accessible musculoskeletal care across our consumer base. Additionally, the Upright Go S presents an attractive option for cost-conscious consumers that we hope will improve membership diversity on our platform. The increased diversity of our members enables our AI-powered personalization engine to deliver more personalized experiences to more users.

1 Anna Zajacova, Hanna Grol-Prokopczyk, Zachary Zimmer; Pain Trends in American Adults, 2002-2018: Patterns, Disparities, and Correlates. Demography April 1, 2021; 58 (2): 711-738. doi:

About DarioHealth Corp.

DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital therapy company that is revolutionizing the way people with chronic conditions manage their health. Dario’s next-generation digital therapy solutions, powered by AI, support more than just an individual’s illness. Dario offers adaptive and personalized experiences that drive behavior change through evidence-based interventions, intuitive and clinically proven digital tools, high-quality software and coaching to help individuals improve their health and achieve results. significant results. Dario offers one of the highest rated diabetes and hypertension solutions on the market. The company’s cross-functional team operates at the intersection of life sciences, behavioral sciences and software technology and is rapidly expanding into new chronic diseases and geographies, using a performance-based approach to improve the health of its users. Dario does the right thing to make the easy thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit

Caution Regarding Forward-Looking Statements

This press release and statements by representatives and partners of DarioHealth Corp. (the “Company” relating thereto) contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical statements made may be deemed to be forward-looking statements. For example, the Company uses forward-looking statements in this press release when it explains that the more it diversifies its membership based on demographic and socio-economic factors, the better informed and less biased the AI-powered personalization engine becomes. and its belief that last year’s impact on human health is driving an incredible demand for more accessible musculoskeletal care across its consumer and customer bases. Without limiting the generality of the foregoing, words such as “plan”, “project”, “potential”, “seek”, “can”, “can”, “hope”, “believe”, “anticipate”, ” intend, “” could “,” estimate “or” continue “are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the actual results of the Company and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company’s results include, but are not limited to, regulatory approvals, product demand, market acceptance, product impact and competitive pricing, product development, marketing or technological difficulties, the success or failure of negotiations and commerce, legal, social and economic risks and risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company’s actual results and forward-looking statements include, without limitation, the risks described in documents filed by the Company with the United States Securities and Exchange Commission. United. Readers are cautioned that actual results (including, without limitation, the timing and results of the Company’s business and regulatory plans for Dario â„¢ as described herein) may differ materially from those set forth in the statements. prospective. The Company does not undertake to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Company Contact
Suzanne Bedell
Vice President Marketing
[email protected]
+ 1-347-767-4220

Media contact:
Josephine Galatioto
[email protected]
+ 1-212-845-4262

SOURCE DarioHealth Corp.

Leave a Reply

Your email address will not be published.